Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3940 | Telesimulation Wiki | 0.71 |
| drug2286 | Maraviroc+Favipiravir+CT Wiki | 0.71 |
| drug1112 | Curently used therapy for COVID-19 non-critical patients Wiki | 0.71 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D007565 | Jaundice, NIH | 1.00 |
| D002761 | Cholangitis NIH | 0.71 |
| D018281 | Cholangiocarcinoma NIH | 0.71 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0030153 | Cholangiocarcinoma HPO | 0.71 |
| HP:0002613 | Biliary cirrhosis HPO | 0.71 |
| HP:0030151 | Cholangitis HPO | 0.71 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0002894 | Neoplasm of the pancreas HPO | 0.35 |
Navigate: Correlations HPO
There are 2 clinical trials
In this study, investigators aim to explore the status of advanced endoscopy in different endoscopy units all over the world.
Description: Investigators will report the baseline demographic data (age, gender, nationality) of all patients.
Measure: Age, gender, nationality Time: 3 monthsDescription: Investigators will report the baseline data clinical data (indication for procedure, status of SARS-CoV-2 infection) of all patients.
Measure: Indication for procedure, status of SARS-CoV-2 infection Time: 3 monthsDescription: Investigators will report the baseline laboratory data (complete blood count and liver functions tests) of all patients.
Measure: Complete blood count and liver functions tests Time: 3 monthsDescription: Investigators will report the procedure related complications.
Measure: procedure related complications Time: 3 monthsDescription: Investigators will report wether the precautions lead to increase timing of the procedure
Measure: Effect of COVID-19 precautions on procedure time Time: 3 monthsDescription: Investigators will report wether the precautions affected staff number (increased or decreased)
Measure: Effect of COVID-19 precautions on staff number Time: 3 monthsThis project will establish that pediatric and family medicine residents who complete a hybrid breastfeeding medicine curriculum that includes an asynchronous unfolding case scenario along with telesimulation with a standardized patient (SP) will provide timely, skilled lactation support more frequently than residents randomized to an asynchronous unfolding case scenario followed by videoconference group discussion regarding care for the breastfeeding dyad.
Description: Breastfeeding medicine practice patterns of physician residents will be assessed at enrollment and following the intervention/control. Physician resident participants will complete a survey querying the number of times they have counseled patients about breastfeeding, the number of breast examinations performed, the number of witnessed breastfeeding sessions, and any experience with counseling about manual expression of breast milk.
Measure: Change in practice patterns Time: at enrollment, 2 weeks and 3 months following interventionDescription: Physician residents (participants) will fill out a survey about their breastfeeding counseling self efficacy prior to and after the intervention.
Measure: Self efficacy Time: at enrollment, 2 weeks and 3 months following interventionDescription: Physician residents (participants) will fill out a survey about their satisfaction with the breast feeding medicine curriculum after the educational intervention.
Measure: Satisfaction with simulation Time: Immediately following the educational interventionAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports